Literature DB >> 8343667

Taste disorders and terbinafine.

M Beutler1, K Hartmann, M Kuhn, J Gartmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8343667      PMCID： PMC1678511          DOI： 10.1136/bmj.307.6895.26-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Taste and smell in disease (first of two parts).

Authors:  S S Schiffman
Journal:  N Engl J Med       Date:  1983-05-26       Impact factor: 91.245

Review 2.  Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.

Authors:  J A Balfour; D Faulds
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546
  2 in total
  6 in total

1.  Drug-induced taste and smell alterations: a case/non-case evaluation of an italian database of spontaneous adverse drug reaction reporting.

Authors:  Marco Tuccori; Francesco Lapi; Arianna Testi; Elisa Ruggiero; Ugo Moretti; Alfredo Vannacci; Roberto Bonaiuti; Luca Antonioli; Matteo Fornai; Giulio Giustarini; Carla Scollo; Tiberio Corona; Fernanda Ferrazin; Laura Sottosanti; Corrado Blandizzi
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

Review 2.  Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.

Authors:  R Davis; J A Balfour
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

3.  Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.

Authors:  M Bräutigam; S Nolting; R E Schopf; G Weidinger
Journal:  BMJ       Date:  1995-10-07

Review 4.  Drug-induced taste disorders.

Authors:  Richard L Doty; Muhammad Shah; Steven M Bromley
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21

6.  Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.

Authors:  Boni Elewski; Amir Tavakkol
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.